Author

Kailan Sierra-Davidson

Harvard UniversityORCID 0000-0001-8265-8620Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Lance L. MunniD· 1 shared Lingshan LiuiD· 1 shared Lutz MenzeliD· 1 shared Meghan J. O’MeliaiD· 1 shared Miranda A. Robert· 1 shared Pin‐Ji LeiiD· 1 shared Sonia CoheniD· 1 shared Timothy P. PaderaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Lance L. MunnORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintSep 22, 2025

The anti-virus T cell response dominates the anti-cancer response in oncolytic virus therapy

Meghan J. O’Melia, Kailan Sierra-Davidson, Miranda A. Robert…·Sonia Cohen

This study shows oncolytic virus therapy primarily elicits anti-virus T cell responses rather than anti-cancer responses, explaining limited clinical efficacy in metastatic disease.

1 citation

humanflow cytometry

𝕏 PostBluesky